Achieve Life Sciences (ACHV) Misses Q1 EPS by 25c
Achieve Life Sciences (NASDAQ: ACHV) reported Q1 EPS of ($0.88), $0.25 worse than the analyst estimate of ($0.63).Rick Stewart, Chairman ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
